SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Henning, R. J.
Right arrow Articles by Li, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henning, R. J.
Right arrow Articles by Li, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cocaine Produces Cardiac Hypertrophy by Protein Kinase C Dependent Mechanisms

Robert J. Henning, MD

Yongxiang Li

University of South Florida College of Medicine and the James A. Haley Hospital, Tampa, Florida

Background: Chronic cocaine users can have as much as a 69% increase in left ventricular muscle mass without associated increases in arterial blood pressure, heart rate, renin, aldosterone, or cortisol. We determined whether cocaine directly increases cardiomyocyte protein content and whether protein kinase C is important in this process.

Methods and Results: Adult rat cardiomyocytes were isolated and grown in cultures. In Series I experiments, cocaine, 10-8 to 10-6 M, or vehicle, in the absence or presence of phentolamine or metoprolol, was added to each culture and the cells were subsequently harvested. In Series II, cocaine, 10-6 M, cocaine, 10-6 M, plus bisindolylmaleimide, 10-6 M, a protein kinase C inhibitor, or vehicle were added to each culture and the cells subsequently harvested. We determined the total protein content, the content of {alpha}-myosin and fetal ß-myosin heavy-chain protein, and the presence of protein kinase C isoforms in the cardiomyocyte soluble and particulate fractions. Protein kinase C translocation from the soluble to particulate fraction is indicative of activation. In Series III, we determined the cocaine effects on ERK, SAPK/JNK, and p38. In Series I, cocaine, 10-8 to 10-6 M, dose-dependently increased myocyte protein content by as much as 28%±2% (P < .001) and fetal,ß-myosin heavy-chain protein content by 80% ± 2% (P < .001). Neither phentolamine nor metoprolol inhibited this process. In Series II, we determined that ventricular myocytes contain alpha ({alpha}), beta (ß), delta ({delta}), epsilon ({epsilon}), and zeta ({xi}) protein kinase C isoforms. Cocaine, 10-6 M, caused a 45 ± 5% increase (P<.001) in protein kinase C{alpha} in the particulate fraction. The addition of a protein kinase C inhibitor to the myocyte cultures prevented the cocaine-induced translocation of protein kinase C{alpha} and limited the increase in ß-myosin heavy-chain protein content by >75% (P<.001). However, cocaine did not increase the phosphorylation of ERK, SAPK/JNK or p38 in Series III.

Conclusions: Cocaine increases adult cardiomyocyte protein content by protein kinase C{alpha}-dependent mechanisms, and this process can contribute to the cardiac hypertrophy and cardiomyopathy that results from chronic cocaine use.

Key Words: cocaine • cardiac myocytes • cell culture/isolation • heart hypertrophy • cardiomy-opathy • heart failure • vasoactive agents • protein kinase C

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 8, No. 2, 149-160 (2003)
DOI: 10.1177/107424840300800208


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
D. H. Tacker, N. K. Herzog, and A. O. Okorodudu
Cocaethylene Affects Human Microvascular Endothelial Cell p38 Mitogen-Activated Protein Kinase Activation and Nuclear Factor-{kappa}B DNA-Binding Activity
Clin. Chem., October 1, 2006; 52(10): 1926 - 1933.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Wenzel, C. Muller, H. M. Piper, and K.-D. Schluter
p38 MAP-kinase in cultured adult rat ventricular cardiomyocytes: expression and involvement in hypertrophic signalling
Eur J Heart Fail, June 1, 2005; 7(4): 453 - 460.
[Abstract] [Full Text] [PDF]



Advertisement